Array Biopharma (ARRY) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.40 +5.00%
Revenue Growth %: -11.6%
Financial Fact:
Weighted average shares outstanding - diluted (in shares): 145.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -11.6%
Financial Fact:
Weighted average shares outstanding - diluted (in shares): 145.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q1 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $6.07 million versus the consensus estimate of $6.35 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
